Vanguard Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,640,151
Closed -$1.19B 4470
2024
Q1
$1.19B Buy
3,640,151
+6,431
+0.2% +$1.58M 0.02% 593
2023
Q4
$692M Buy
3,633,720
+33,539
+0.9% +$6.34M 0.02% 792
2023
Q3
$717M Sell
3,600,181
-2,833
-0.1% -$670K 0.02% 721
2023
Q2
$1.03B Sell
3,603,014
-137,387
-4% -$38.2M 0.02% 599
2023
Q1
$811M Buy
3,740,401
+45,470
+1% +$8.86M 0.02% 662
2022
Q4
$760M Buy
3,694,931
+163,646
+5% +$41.4M 0.02% 676
2022
Q3
$982M Buy
3,531,285
+13,619
+0.4% +$3.46M 0.03% 569
2022
Q2
$672M Buy
3,517,666
+206,109
+6% +$36.4M 0.02% 703
2022
Q1
$687M Buy
3,311,557
+67,789
+2% +$11.2M 0.02% 784
2021
Q4
$578M Buy
3,243,768
+51,602
+2% +$10.2M 0.01% 909
2021
Q3
$657M Buy
3,192,166
+216,384
+7% +$42.5M 0.02% 816
2021
Q2
$565M Buy
2,975,782
+86,004
+3% +$14.1M 0.01% 918
2021
Q1
$376M Buy
2,889,778
+96,889
+3% +$11.6M 0.01% 1139
2020
Q4
$290M Buy
2,792,889
+563,951
+25% +$48.8M 0.01% 1223
2020
Q3
$169M Buy
2,228,938
+225,970
+11% +$12.8M 0.01% 1378
2020
Q2
$94.9M Buy
2,002,968
+267,559
+15% +$11M ﹤0.01% 1704
2020
Q1
$57.6M Buy
1,735,409
+30,277
+2% +$1.2M ﹤0.01% 1804
2019
Q4
$74.9M Buy
1,705,132
+994,688
+140% +$36.7M ﹤0.01% 1909
2019
Q3
$21.3M Buy
710,444
+44,348
+7% +$1.88M ﹤0.01% 2467
2019
Q2
$38M Buy
666,096
+616,096
+1,232% +$29.9M ﹤0.01% 2241
2019
Q1
$1.67M Buy
+50,000
New +$1.66M ﹤0.01% 3506

Other funds holding SWAV

Vanguard Group's SWAV Position: Q2 2024 in Review

Vanguard Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,640,151 shares — an estimated $1.19B sold.

Vanguard Group first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $1.19B in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Vanguard Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vanguard Group sold 3,640,151 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.19B.
  • Vanguard Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Vanguard Group's Shockwave Medical, Inc. Common Stock position peaked at $1.19B in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.